Research to date has shown that depressive disorders and symptoms are frequently associated with MA use. The National Epidemiologic Survey on Alcohol and Related Conditions (NESARC) utilized the Alcohol Use Disorder and Associated Disabilities Interview Schedule-DSM-IV Version (AUDADIS-IV) to assess psychiatric diagnoses in a probability sample of 43,093 subjects (Stinson et al., 2005; Conway et al., 2006). The lifetime prevalence of mood disorder among participants with amphetamine dependence was 64%. 1 The studies did not report on participants diagnosed with substance-induced disorders (Stinson et al., 2005; Conway et al., 2006). Lifetime prevalence of psychiatric diagnoses was assessed using the Structured Clinical Interview for DSM-IV Disorders (SCID) in 155 gay or bisexual men seeking treatment for MA abuse or dependence (Shoptaw et al., 2003). Mood disorders were found in 52% of the sample; of which 41% of subjects met criteria for substance-induced mood disorders.
